microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients
ConclusionsThe ampTSmiR test is more sensitive than the conventional TGCC protein biomarkers for the detection of residual disease and relapse, excluding mature teratoma.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Seminoma | Stem Cell Therapy | Stem Cells | Teratoma | Testicular Cancer